Search research articles
Contact Us
Filters
Showing results (11-20 of 52) with videos related to
Page
of 6
Sort By:
Oncoimmunology
|
January 9, 2024
Single-cell analysis of T lymphocytes infiltrating colorectal carcinoma: the dilemma of specificity
Manuela Lizarralde-Guerrero, Laura Zucaro, Guido Kroemer, et al.
Oncoimmunology
|
July 30, 2024
Targeted opening of the blood-brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma
Jonathan G Pol, Manuela Lizarralde-Guerrero, Andrea Checcoli, et al.
Oncoimmunology
|
October 10, 2022
PDIA3 as a potential bridge between immunogenic cell death and autoreactivity
Jonathan G Pol, Céleste Plantureux, María Pérez-Lanzón, et al.
The Journal of Experimental Medicine
|
October 16, 2019
Effects of interleukin-2 in immunostimulation and immunosuppression
Jonathan G Pol, Pamela Caudana, Juliette Paillet, et al.
Oncoimmunology
|
July 10, 2025
Disruption of cholesterol homeostasis by antidepressants induces immunogenic cell death
Karla Alvarez-Valadez, Jonathan G Pol, Guido Kroemer, et al.
Trends in Immunology
|
December 25, 2017
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
Shashi Gujar, Jonathan G Pol, Youra Kim, et al.
Cytokine & Growth Factor Reviews
|
November 13, 2020
Cytokines in oncolytic virotherapy
Jonathan G Pol, Samuel T Workenhe, Prathyusha Konda, et al.
Oncoimmunology
|
October 22, 2021
Trial watch: intratumoral immunotherapy
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 2, 2013
Panorama from the oncolytic virotherapy summit
Jonathan G Pol, Monique Marguerie, Rozanne Arulanandam, et al.
Oncoimmunology
|
May 31, 2019
Trial watch: dietary interventions for cancer therapy
Sarah Lévesque, Jonathan G Pol, Gladys Ferrere, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 52) with videos related to
Sort By:
Page
of 6
Oncoimmunology
|
January 9, 2024
Single-cell analysis of T lymphocytes infiltrating colorectal carcinoma: the dilemma of specificity
Manuela Lizarralde-Guerrero, Laura Zucaro, Guido Kroemer, et al.
Oncoimmunology
|
July 30, 2024
Targeted opening of the blood-brain barrier facilitates doxorubicin/anti-PD-1-based chemoimmunotherapy of glioblastoma
Jonathan G Pol, Manuela Lizarralde-Guerrero, Andrea Checcoli, et al.
Oncoimmunology
|
October 10, 2022
PDIA3 as a potential bridge between immunogenic cell death and autoreactivity
Jonathan G Pol, Céleste Plantureux, María Pérez-Lanzón, et al.
The Journal of Experimental Medicine
|
October 16, 2019
Effects of interleukin-2 in immunostimulation and immunosuppression
Jonathan G Pol, Pamela Caudana, Juliette Paillet, et al.
Oncoimmunology
|
July 10, 2025
Disruption of cholesterol homeostasis by antidepressants induces immunogenic cell death
Karla Alvarez-Valadez, Jonathan G Pol, Guido Kroemer, et al.
Trends in Immunology
|
December 25, 2017
Antitumor Benefits of Antiviral Immunity: An Underappreciated Aspect of Oncolytic Virotherapies
Shashi Gujar, Jonathan G Pol, Youra Kim, et al.
Cytokine & Growth Factor Reviews
|
November 13, 2020
Cytokines in oncolytic virotherapy
Jonathan G Pol, Samuel T Workenhe, Prathyusha Konda, et al.
Oncoimmunology
|
October 22, 2021
Trial watch: intratumoral immunotherapy
Juliette Humeau, Julie Le Naour, Lorenzo Galluzzi, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
October 2, 2013
Panorama from the oncolytic virotherapy summit
Jonathan G Pol, Monique Marguerie, Rozanne Arulanandam, et al.
Oncoimmunology
|
May 31, 2019
Trial watch: dietary interventions for cancer therapy
Sarah Lévesque, Jonathan G Pol, Gladys Ferrere, et al.
Page
of 6